How to get Mounjaro if you're not obese: the UK eligibility rules explained

What the licensed eligibility threshold actually means for people with a BMI under 30

The widespread assumption that Mounjaro is only for people with a BMI of 30 or above is understandable but not quite accurate. The UK licence for tirzepatide (Mounjaro's active ingredient) covers adults with a BMI at or above 27 kg/m², as long as at least one weight-related condition is also present. That condition might be high blood pressure, dyslipidaemia, type 2 diabetes, prediabetes, obstructive sleep apnoea, or osteoarthritis, among others. Lower thresholds apply for some ethnic backgrounds under UK guidance, recognising that the relationship between BMI and health risk varies across populations.

NICE's appraisal of tirzepatide (TA1026) sets a higher bar for NHS access, requiring a BMI of 35 or above alongside comorbidities, and our page on how to get Mounjaro on the NHS explains what that pathway involves and who currently qualifies. Private prescribing follows the licence, which is why a BMI of 27 to 29.9 with a qualifying condition is a legitimate clinical pathway — subject to a prescriber deciding it is right for you specifically. Meeting the threshold on paper is the start of the conversation, not the end of it.

The evidence base that shaped the licence included participants across a range of weight categories. SURMOUNT-1, published in the New England Journal of Medicine, studied tirzepatide in thousands of adults with obesity or overweight plus at least one comorbidity, and the results fed directly into the regulatory assessment of who might benefit. A prescriber considers that evidence alongside your individual circumstances.

The only legal route: a prescription following clinical assessment

There is no shortcut to getting Mounjaro. As a prescription-only medicine, it cannot legally be supplied without a valid prescription issued after clinical assessment, and that assessment must be conducted by a qualified, registered prescriber. The NHS medicines page for tirzepatide sets out clearly that it is a POM; your GP or a licensed online prescriber must be the gatekeeper.

At nume, that process runs as follows. You complete a detailed medical questionnaire. A GPhC-registered Independent Prescriber (a named clinician, not an algorithm) reads your answers the same day. If you are a new patient, identity is verified with photo ID, and weight is confirmed on a live video call. Your GP is notified in line with GPhC guidance. If your prescriber is satisfied that treatment is clinically appropriate, a prescription is issued and your order is dispatched. If it is not appropriate, you are told why, clearly, with no prescription written and no medicine sent. That is the process. It is not a formality.

People sometimes ask whether an online pharmacy is a legitimate route compared with seeing a GP. Getting Mounjaro through your GP is one valid path; a regulated online pharmacy is another. Both must follow the same clinical standards. The difference is speed and availability, NHS waiting lists for specialist weight management services can be long, and our full guide on how to get Mounjaro walks through every available route and what each one involves.

How to check you are dealing with a safe, legal pharmacy

The MHRA has warned publicly about fake weight-loss pens sold through social media and informal online sellers. In October 2025, enforcement teams raided the first illicit UK site manufacturing counterfeit tirzepatide pens. Around 20 million doses of illegally traded weight-loss medicines, with an estimated street value of around £45 million, have been seized in enforcement action. Counterfeit pens have been found to contain insulin. The consequences can be serious.

Before handing over any payment or personal health information, verify the pharmacy on the GPhC register. You can search by registration number directly: nume's GPhC premises registration is 9012878, verifiable in seconds. Any legitimate online pharmacy will have a registration you can check the same way. Sellers who cannot point you to a GPhC entry, who offer these medicines without a prior clinical assessment, or who promote discount codes and unusually low prices should be treated as red flags. Suspect sellers can be reported to the MHRA via the Yellow Card scheme.

This is worth being specific about: the MHRA's guidance is clear that GLP-1 medicines are not assessed for quick or cosmetic weight loss, they are serious prescription treatments. Choosing a registered, clinician-led pharmacy is not a premium option. It is the safe one. More on how to get Mounjaro safely online covers the due-diligence steps in full.

Starting Mounjaro at a lower BMI: what to expect from the consultation

If your BMI sits between 27 and 30 and you have a qualifying condition, the consultation is your opportunity to make the case, and to have a clinician make an honest assessment in return. Our prescribers will look at your medical history, current medications, the nature and severity of your weight-related condition, and whether lifestyle measures have been tried. BMI is one input, not a verdict.

Treatment begins at the 2.5mg dose regardless of starting weight, and if you want to understand exactly what that first step involves, our page on buying Mounjaro at the starting dose of 2.5mg explains what to expect from that initial pen. Titration is guided by your prescriber at every repeat, not by a fixed schedule you follow alone, and if you ever reach your goal and want to understand your options, our guide on how to get off Mounjaro explains how stopping is managed safely. For a broader view of the weight-loss treatments we offer, our weight-loss overview is a useful starting point.

Questions after reading this? Our FAQs cover many of the practical details, and our contact page connects you with aftercare support seven days a week. When you are ready, the next step is a free consultation, no commitment until a prescription is clinically appropriate and you choose to proceed.